Ekroos; Kim

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ekroos; Kim.The latest application filed is for "lipidomic biomarkers for identification of high-risk coronary artery disease patients".

Company Profile

6.19.24

Ekroos; Kim - Helsinki FI
Ekroos; Kim - Espoo FI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients App 20210239719 - Laaksonen; Reijo ; et al.	2021-08-05
Lipidomic biomarkers for identification of high-risk coronary artery disease patients Grant 10,955,427 - Laaksonen , et al. March 23, 2	2021-03-23
Lipidomic Biomarkers For Atherosclerosis And Cardiovascular Disease App 20210003598 - Laaksonen; Reijo ; et al.	2021-01-07
Lipidomic biomarkers for atherosclerosis and cardiovascular disease Grant 10,551,394 - Laaksonen , et al. Fe	2020-02-04
Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients App 20200003794 - Laaksonen; Reijo ; et al.	2020-01-02
Lipidomic biomarkers for identification of high-risk coronary artery disease patients Grant 10,261,101 - Laaksonen , et al.	2019-04-16
USE OF CERAMIDES AND LPLs IN DIAGNOSING CVD App 20190086386 - Sysi-Aho; Marko ; et al.	2019-03-21
Lipidomic Biomarkers For Atherosclerosis And Cardiovascular Disease App 20180321266 - Laaksonen; Reijo ; et al.	2018-11-08
Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients App 20180067138 - Laaksonen; Reijo ; et al.	2018-03-08
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment Grant 9,863,965 - Laaksonen , et al. January 9, 2	2018-01-09
Lipidomic biomarkers for atherosclerosis and cardiovascular disease Grant 9,857,386 - Laaksonen , et al. January 2, 2	2018-01-02
Lipidomic biomarkers for identification of high-risk coronary artery disease patients Grant 9,841,431 - Laaksonen , et al. December 12, 2	2017-12-12
USE OF CERAMIDES AND LPLs IN DIAGNOSING CVD App 20170160264 - Sysi-Aho; Marko ; et al.	2017-06-08
Biomarkers for sensitive detection of statin-induced muscle toxicity Grant 9,664,698 - Laaksonen , et al. May 30, 2	2017-05-30
Biomarkers For Sensitive Detection Of Statin-induced Muscle Toxicity App 20170082644 - Laaksonen; Reijo ; et al.	2017-03-23
Biomarkers for sensitive detection of statin-induced muscle toxicity Grant 9,541,565 - Laaksonen , et al. January 10, 2	2017-01-10
Lipidomic Biomarkers For Atherosclerosis And Cardiovascular Disease App 20160363601 - Laaksonen; Reijo ; et al.	2016-12-15
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Undergoing Statin Treatment App 20160363602 - Laaksonen; Reijo ; et al.	2016-12-15
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Not Undergoing Statin Treatment App 20160320418 - Laaksonen; Reijo ; et al.	2016-11-03
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment Grant 9,459,265 - Laaksonen , et al. October 4, 2	2016-10-04
Lipidomic biomarkers for atherosclerosis and cardiovascular disease Grant 9,459,264 - Laaksonen , et al. October 4, 2	2016-10-04
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment Grant 9,423,406 - Laaksonen , et al. August 23, 2	2016-08-23
Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients App 20160025751 - Laaksonen; Reijo ; et al.	2016-01-28
Lipidomic biomarkers for identification of high-risk coronary artery disease patients Grant 9,201,080 - Laaksonen , et al. December 1, 2	2015-12-01
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Not Undergoing Statin Treatment App 20150260737 - Laaksonen; Reijo ; et al.	2015-09-17
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Undergoing Statin Treatment App 20150260738 - Laaksonen; Reijo ; et al.	2015-09-17
Lipidomic Biomarkers For Atherosclerosis And Cardiovascular Disease App 20150247873 - LAAKSONEN; Reijo ; et al.	2015-09-03
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment Grant 9,052,327 - Laaksonen , et al. June 9, 2	2015-06-09
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment Grant 9,052,328 - Laaksonen , et al. June 9, 2	2015-06-09
Lipidomic biomarkers for atherosclerosis and cardiovascular disease Grant 9,046,538 - Laaksonen , et al. June 2, 2	2015-06-02
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Undergoing Statin Treatment App 20140295466 - Laaksonen; Reijo ; et al.	2014-10-02
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Not Undergoing Statin Treatment App 20140295467 - Laaksonen; Reijo ; et al.	2014-10-02
Biomarkers for Sensitive Detection of Statin-Induced Muscle Toxicity App 20140031332 - Laaksonen; Reijo ; et al.	2014-01-30
Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients App 20130216560 - Laaksonen; Reijo ; et al.	2013-08-22
Lipidomic Biomarkers For Atherosclerosis And Cardiovascular Disease App 20130045217 - Laaksonen; Reijo ; et al.	2013-02-21
Biomarkers For Sensitive Detection Of Statin-induced Muscle Toxicity App 20120258123 - Laaksonen; Reijo ; et al.	2012-10-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.